-
Mashup Score: 22Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin | Blood Cancer Talks | Episode 47 - 9 month(s) ago
In this episode, we dive into updates in Minimal Residual Disease (MRD) in multiple myeloma, along with the FDA ODAC meeting in April 2024 to decide on MRD as a surrogate endpoint for accelerated approval. Our guests are Dr. Benjamin Derman and Dr. Manni Mohyuddin. Here are the key papers we…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 25Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi | Blood Cancer Talks | Episode 43 - 11 month(s) ago
In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi from University of Arkansas Myeloma Center. RCTs of BCMA CAR T-cell Therapy in Early Relapsed Multiple Myeloma:a) KarMMa-3 (ide-cel):…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
Tune in to our new episode on CAR T-cell therapy in early relapsed #MultipleMyeloma with @HadidiSamer! We dissect the data presented at @FDAOncology ODAC and how to make sense of it in clinical practice as we anticipate approval soon! https://t.co/4kWqQPcFFo https://t.co/8aKWnLeG0m
-
-
Mashup Score: 34Episode 40. Management of Newly Diagnosed AL Amyloidosis | Blood Cancer Talks | Episode 41 - 1 year(s) ago
In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. Here are the key articles discussed:1. Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/ 2. Mayo 2004 staging: …
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
Tune in to our new episode on management of AL Amyloidosis with @ADispenzieri! We dive into the nuances of management including tissue biopsy, risk stratification, monitoring patients while on Dara-VCD, and many more critical issues! https://t.co/qH9gsov1p5 Check out this clip: https://t.co/gnMRfBAu1s
-
-
Mashup Score: 30Blood Cancer Talks: Episode 38. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel on Apple Podcasts - 1 year(s) ago
Show Blood Cancer Talks, Ep Episode 38. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel – Feb 8, 2024
Source: comsync.lijit.comCategories: General Medicine News, Partners & KOLsTweet-
Tune in to our new episode on #ASH23 myeloid recap with @Anand_88_Patel! We discuss TRANSFORM-1 MANIFEST-2 FILO AUGMENT-101 and more! https://t.co/sLn0EGiFZI @AshKishtagari Here is a clip on FILO study https://t.co/fIMI02p0FM
-
-
Mashup Score: 41Blood Cancer Talks: Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan on Apple Podcasts - 1 year(s) ago
Show Blood Cancer Talks, Ep Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan – Jan 19, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
🔥Our latest episode on GVHD ppx in allo-transplant with @sghmd! As @sghmd says, "𝐰𝐞 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐝𝐨 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐰𝐞 𝐜𝐚𝐧 𝐭𝐨 𝐚𝐯𝐨𝐢𝐝 𝐠𝐢𝐯𝐢𝐧𝐠 𝐡𝐢𝐠𝐡 𝐝𝐨𝐬𝐞 𝐬𝐭𝐞𝐫𝐨𝐢𝐝𝐬"! 👇Clip on BMT CTN 1203 and GRFS endpoint! https://t.co/cgCgucGqU3 https://t.co/MMI0Y8WtQb
-
-
Mashup Score: 39Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman | Blood Cancer Talks | Episode 38 - 1 year(s) ago
In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode: First, we will focus on a few abstracts in precursor states, MGUS. 1. New diagnostic criteria for light chain MGUS…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
🔥🔥 Tune in for our #ASH23 #Myeloma recap with @bdermanmd! We discuss: PERSEUS ISKIA GMMG ReLApsE KarMMa-3 OS data @iStopMM serum FLC ratio GEM2017FIT And many clinical pearls on MRD! #mmsm #bmtsm https://t.co/t24N0TuZR8 https://t.co/LziqDB54Vr
-
-
Mashup Score: 8Blood Cancer Talks: Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma on Apple Podcasts - 1 year(s) ago
Show Blood Cancer Talks, Ep Episode 26. Management of Newly Diagnosed Hodgkin’s Lymphoma – Jul 15, 2023
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
🌟Our top downloaded episode of 2023 featured the brilliant Dr. Nancy Bartlett discussing Hodgkin lymphoma! 🎙️Delve into her insightful analysis of pivotal trials, where she skillfully navigates the delicate balance between enthusiasm and skepticism #lymsm https://t.co/VahbHn08Hc https://t.co/ynKVU6hYLW
-
-
Mashup Score: 31Blood Cancer Talks: Episode 36. ASH 2023 Lymphoma Recap with Dr. Toby Eyre on Apple Podcasts - 1 year(s) ago
Show Blood Cancer Talks, Ep Episode 36. ASH 2023 Lymphoma Recap with Dr. Toby Eyre – Dec 20, 2023
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
Tune in to our #ASH23 lymphoma/CLL recap with @tobyeyre82! We delved into key abstracts, from the phase 3 SYMPATICO trial in Mantle Cell Lymphoma to insights on Smart Stop and Mosun-Pola in DLBCL! @Eddie_Cliff #lymsm https://t.co/PgasqKuzfx https://t.co/AcWjTJTqxY
-
-
Mashup Score: 31Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson | Blood Cancer Talks | Episode 36 - 1 year(s) ago
In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, Australia. Here are the key articles we discussed: 1. Glofitamab for Relapsed/Refractory DLBCL:https://pubmed.ncbi.nlm.nih.gov/36507690/ 2….
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
🔥 Our new episode on Bispecific Antibodies in #lymphoma just dropped! Dr. Michael Dickinson @PeterMacCC provides a comprehensive overview on the state of current literature and how bsAbs might shape the future of DLBCL treatment! https://t.co/c7V462DrVX #lymsm @Eddie_Cliff https://t.co/RyiPDJo7PG
-
-
Mashup Score: 25Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson | Blood Cancer Talks | Episode 36 - 1 year(s) ago
In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, Australia. Here are the key articles we discussed: 1. Glofitamab for Relapsed/Refractory DLBCL:https://pubmed.ncbi.nlm.nih.gov/36507690/ 2….
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
🔥 Our new episode on Bispecific Antibodies in #lymphoma just dropped! Dr. Michael Dickinson @PeterMacCC provides a comprehensive overview on the state of current literature and how bsAbs might shape the future of DLBCL treatment! https://t.co/c7V462DrVX #lymsm @Eddie_Cliff https://t.co/RyiPDJo7PG
-
Tune in to our brand new episode on updates in #Myeloma MRD with @bdermanmd and @ManniMD1, including a spirited discussion on the recent ODAC meeting! You won't want to miss it! https://t.co/OyvwSNw80B https://t.co/tjJ69ZtVF9